Clinical Trials match your criteria
-
Combo Chemo w/ or w/o Torisel Treating Rhabdomyosarcoma
A Randomized Phase 3 Study of Vincristine, Dactinomycin, Cyclophosphamide (VAC) Alternating with Vincristine and Irinotecan (VI) Versus VAC/VI Plus Temsirolimus (TORI, Torisel, NSC# 683864, IND# 122782) in Patients with Intermediate Risk (IR) Rhabdomyosarcoma (RMS)
-
NMTT- Neuroblastoma Maintenance Therapy Trial Using DFMO
NMTT- Neuroblastoma Maintenance Therapy Trial Using Difluoromethylornithine (DFMO)
-
Craniopharyngioma - Identifying Bio Targets for Medical Therapy
Advancing Treatment for Pediatric Craniopharyngioma: Prospective Pilot Study Identifying Clinically Relevant Biological Targets for Medical Therapy
-
Project:EveryChild - A Registry, Eligibility Screening, Biology and Outcome Study
Project: EveryChild a Registry, Eligibility Screening, Biology and Outcome Study
-
Determining the Natural and Unnatural History of AAOCA
Determining the Natural and Unnatural History of Anomalous Aortic Origin of a Coronary Artery with an Interarterial Course: Establishing a Multi-Institutional Registry
-
Unbalanced Atrioventricular Septal Defect Study
Unbalanced Atrioventricular Septal Defect: A Congenital Heart Surgeons' Society Inception Cohort Study
-
Brain Tumor Tissue Collection
Establishment of a UF Brain Tumor Tissue Bank: Florida Center for Brain Tumor Research
-
ICN
Improve Care Now
-
Response & Biology Based Risk Factor Guided Therapy Treating Patients w/Non-high Risk Neuroblastoma
Utilizing Response and Biology Based Risk Factors to Guide Therapy in Patients with Non-High Risk Neuroblastoma
